04.06.2018
- Wolfgang Wienand has been appointed as new CEO of Siegfried with effect from Jan. 1, 2019. Rudolf Hanko, the group’s current CEO, will step down on Dec. 31, 2018. The board has...
25.09.2015
- Siegfried Holding, the Swiss drug contract manufacturer, said it has completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the...
07.05.2015
- BASF has announced that it will sell its custom synthesis business, part of its Nutrition & Health division, and parts of its current active pharmaceutical ingredients (APIs)...
01.10.2014
- 1. What roles do contract research organizations (CROs) and contract manufacturing organizations (CMOs) play in the drug discovery/development value chain today, and how will their...
01.10.2014
- Pharmaceutical companies have outsourced several critical steps in the discovery and development of new drugs and the scale-up of processes and the manufacturing of APIs. Pharma...
11.09.2013
- Happy Birthday — If Siegfried were to actually light all of the candles on its birthday cake this year, the company might get a visit from plant fire department. The Swiss custom...
